Latest News - ResMed
Top Corporates Hub
ResMed
3 Reasons Investors Watch ResMed (RMD)
28.08.2025 04:01
ResMed has had an impressive run over the past six months as its shares have beaten the S&P 500 by 11.9%. The stock now trades at $281.96, marking a 20.7% gain. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.
Respiratory Care Devices Market Landscape Report 2025-2030 Featuring Major Players - Koninklijke Philips, Medtronic, ResMed, Fisher & Paykel Healthcare, and Dragerwerk
26.08.2025 08:41
The global respiratory care devices market is projected to grow from USD 23.6 billion in 2025 to USD 33.6 billion by 2030, with a CAGR of 7.3%. This growth is driven by increasing respiratory diseases due to aging, smoking, and pollution. Notably, therapeutic devices like CPAP, BiPAP, and nebulizers dominate the market, crucial for conditions like COPD and sleep apnea. North America leads the market, bolstered by robust healthcare systems and awareness of respiratory health. Key players include
1 Healthcare Stock Worth Investigating and 2 Facing Challenges
20.08.2025 04:33
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 7.1%. This drawdown is a far cry from the S&P 500’s 4.7% ascent.
Here's How Much You'd Have If You Invested $1000 in ResMed a Decade Ago
11.08.2025 12:30
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
ResMed Full Year 2025 Earnings: EPS Beats Expectations
11.08.2025 10:57
NYSE:RMD 1 Year Share Price vs Fair Value Explore ResMed's Fair Values from the Community and select yours ResMed...
Ventilators Company Evaluation Report 2025 - ResMed, Getinge, and Philips Lead the Ventilator Market Through Innovation, Strong Global Presence, and Strategic Use of Technology and Partnerships
04.08.2025 08:04
The Ventilator Companies Quadrant offers an in-depth analysis of the global ventilators market, spotlighting top players like ResMed, Getinge AB, and Koninklijke Philips N.V. This report highlights technological advancements in portable ventilators and sensor tech, driven by rising preterm births, aging demographics, increasing respiratory ailments, and growing home oxygen therapy preferences. Key players are shaping the market through innovation, strategic partnerships, and global expansion. De
US$290 - That's What Analysts Think ResMed Inc. (NYSE:RMD) Is Worth After These Results
02.08.2025 13:25
As you might know, ResMed Inc. ( NYSE:RMD ) recently reported its full-year numbers. ResMed reported US$5.1b in...
ResMed (RMD) To Report Earnings Tomorrow: Here Is What To Expect
30.07.2025 03:08
Medical device company ResMed (NYSE:RMD) will be reporting earnings this Thursday afternoon. Here’s what investors should know.
ResMed AirSense 11 AutoSet Launches at O2Xpress, Offering Unparalleled Innovation for Advanced Sleep Apnea Treatment
11.07.2025 04:46
O2Xpress is excited to announce the addition of the state-of-the-art ResMed AirSense 11 AutoSet to its extensive range of premium sleep therapy solutions. Engineered by global healthcare leader...
ResMed Inc.(NYSE: RMD) dropped from Russell 1000 Dynamic Index
30.06.2025 14:57
ResMed Inc. dropped from Russell 1000 Dynamic Index...
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
30.06.2025 13:45
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks.com featured highlights Sprouts Farmers Market, Adobe, GE Aerospace and ResMed
26.06.2025 08:40
SFM, ADBE, GE, and RMD stand out as GARP stocks blending solid growth potential with reasonable valuations for smart returns.
ResMed : Compliance, Privacy and Quality Committee Charter
19.06.2025 09:14
RESMED INC. COMPLIANCE, PRIVACY AND QUALITY COMMITTEE CHARTER The ResMed Inc. Board of Directors adopted this amended Compliance, Privacy and Quality Committee Charter...
ResMed’s Q1 Earnings Call: Our Top 5 Analyst Questions
18.06.2025 12:27
ResMed’s first quarter results were met with a strong market response, reflecting in-line revenue and profit performance alongside notable margin expansion. Management credited manufacturing and logistics efficiencies, positive product mix shifts, and sustained demand in both devices and masks as primary contributors to improved profitability. CEO Mick Farrell emphasized the benefits of investments in automation and U.S.-based production, stating, “Our results are a testament to the work that we
ResMed: A Sleeping Giant Hiding In Plain Sight
09.06.2025 05:38
ResMed dominates an enormous, underdiagnosed market with recurring revenue and digital health leadership. Read why RMD stock is a Strong Buy.
Q1 Patient Monitoring Earnings: Insulet (NASDAQ:PODD) Earns Top Marks
05.06.2025 03:33
Earnings results often indicate what direction a company will take in the months ahead. With Q1 behind us, let’s have a look at Insulet (NASDAQ:PODD) and its peers.
ResMed (RMD) is a Top-Ranked Growth Stock: Should You Buy?
04.06.2025 13:45
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Reflecting On Patient Monitoring Stocks’ Q1 Earnings: Masimo (NASDAQ:MASI)
03.06.2025 03:31
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Masimo (NASDAQ:MASI) and the rest of the patient monitoring stocks fared in Q1.
2 Healthcare Stocks to Keep an Eye On and 1 to Turn Down
02.06.2025 04:35
From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of COVID-19, and over the past six months, the industry has pulled back by 13.2%. This performance was significantly worse than the S&P 500’s 2.4% decline.